First Time Loading...

Luxi Chemical Group Co Ltd
SZSE:000830

Watchlist Manager
Luxi Chemical Group Co Ltd Logo
Luxi Chemical Group Co Ltd
SZSE:000830
Watchlist
Price: 12.17 CNY 0.91% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

35.3B
-0.5%
Assets
Growth Rates:
1 Year
+3%
3 Years
+11%
5 Years
+27%
7 Years
+41%
10 Years
+97%
18.4B
-2%
Liabilities
Growth Rates:
1 Year
+8%
3 Years
+4%
5 Years
+8%
7 Years
+11%
10 Years
+50%
16.9B
+2%
Equity
Growth Rates:
1 Year
-3%
3 Years
+18%
5 Years
+57%
7 Years
+100%
10 Years
+201%

Balance Sheet Decomposition
Luxi Chemical Group Co Ltd

35.3B
Assets
18.4B
Liabilities
35.3B
Assets
18.4B
Liabilities
Current Assets 2.5B
Cash & Short-Term Investments 382.1m
Receivables 210.1m
Other Current Assets 1.9B
Non-Current Assets 32.8B
Long-Term Investments 77.7m
PP&E 27.5B
Intangibles 2.3B
Other Non-Current Assets 2.9B
Current Liabilities 13.9B
Accounts Payable 1.4B
Accrued Liabilities 359.1m
Short-Term Debt 8.6B
Other Current Liabilities 3.5B
Non-Current Liabilities 4.5B
Long-Term Debt 3.3B
Other Non-Current Liabilities 1.2B

Balance Sheet
Luxi Chemical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
544
973
945
772
579
559
277
344
274
382
Cash
0
0
0
0
0
0
0
344
274
382
Cash Equivalents
544
973
945
772
579
559
277
0
0
0
Total Receivables
802
792
806
881
453
1 197
1 095
323
483
210
Accounts Receivables
37
70
43
102
102
103
57
91
62
35
Other Receivables
765
722
763
779
351
1 094
1 038
232
421
175
Inventory
1 495
1 485
1 547
1 512
1 053
1 301
1 891
1 771
1 676
1 597
Other Current Assets
260
161
356
242
229
551
434
379
381
290
Total Current Assets
3 101
3 411
3 655
3 406
2 314
3 608
3 697
2 817
2 815
2 479
PP&E Net
15 345
17 729
20 000
22 647
23 694
24 151
25 212
24 791
26 500
27 467
PP&E Gross
15 345
17 729
20 000
22 647
23 694
0
25 212
24 791
26 500
27 467
Accumulated Depreciation
5 825
7 009
8 247
8 971
10 452
0
12 681
14 548
16 417
18 384
Intangible Assets
838
959
1 118
1 401
1 458
1 488
1 922
1 989
2 322
2 322
Note Receivable
0
0
0
0
0
734
734
868
664
595
Long-Term Investments
159
186
201
203
193
293
53
87
84
78
Other Long-Term Assets
419
82
89
118
132
656
256
1 565
2 023
2 342
Total Assets
19 862
N/A
22 367
+13%
25 065
+12%
27 775
+11%
27 791
+0%
30 930
+11%
31 874
+3%
32 116
+1%
34 407
+7%
35 282
+3%
Liabilities
Accounts Payable
1 792
1 560
1 776
2 231
1 365
971
918
829
1 454
1 447
Accrued Liabilities
172
181
170
243
306
66
465
674
591
359
Short-Term Debt
7 258
7 753
8 981
9 478
10 254
8 637
10 367
5 548
7 144
8 595
Current Portion of Long-Term Debt
510
619
383
2 300
498
533
1 095
291
1 908
2 463
Other Current Liabilities
1 009
1 150
786
1 096
1 247
4 809
1 186
1 755
892
1 015
Total Current Liabilities
10 741
11 263
12 095
15 348
13 670
15 015
14 031
9 097
11 990
13 880
Long-Term Debt
2 855
2 794
3 335
955
2 330
2 983
2 089
3 784
3 721
3 273
Deferred Income Tax
0
6
7
7
97
341
403
395
507
444
Minority Interest
0
150
200
238
238
125
125
126
126
127
Other Liabilities
291
340
986
973
708
1 132
965
769
735
663
Total Liabilities
13 887
N/A
14 554
+5%
16 623
+14%
17 521
+5%
17 041
-3%
19 597
+15%
17 613
-10%
14 172
-20%
17 078
+21%
18 386
+8%
Equity
Common Stock
1 465
1 465
1 465
1 465
1 465
1 465
1 904
1 904
1 920
1 916
Retained Earnings
2 324
2 167
2 297
4 111
6 607
7 501
7 573
11 255
10 582
10 175
Additional Paid In Capital
2 184
2 184
2 184
2 184
2 181
2 370
4 787
4 787
4 946
4 905
Treasury Stock
0
0
0
0
0
0
0
0
115
98
Other Equity
3
1 997
2 495
2 494
497
3
3
2
2
3
Total Equity
5 975
N/A
7 813
+31%
8 441
+8%
10 254
+21%
10 749
+5%
11 333
+5%
14 261
+26%
17 944
+26%
17 330
-3%
16 896
-3%
Total Liabilities & Equity
19 862
N/A
22 367
+13%
25 065
+12%
27 775
+11%
27 791
+0%
30 930
+11%
31 874
+3%
32 116
+1%
34 407
+7%
35 282
+3%
Shares Outstanding
Common Shares Outstanding
1 465
1 465
1 465
1 465
1 465
1 465
1 465
1 904
1 904
1 898

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.